157 related articles for article (PubMed ID: 9112103)
1. Co-administration of the neurotrophic ACTH(4-9) analogue, ORG 2766, may reduce the cochleotoxic effects of cisplatin.
de Groot JC; Hamers FP; Gispen WH; Smoorenburg GF
Hear Res; 1997 Apr; 106(1-2):9-19. PubMed ID: 9112103
[TBL] [Abstract][Full Text] [Related]
2. Histological effects of co-administration of an ACTH((4-9)) analogue, ORG 2766, on cisplatin ototoxicity in the albino guinea pig.
Cardinaal RM; de Groot JC; Huizing EH; Veldman JE; Smoorenburg GF
Hear Res; 2000 Jun; 144(1-2):157-67. PubMed ID: 10831874
[TBL] [Abstract][Full Text] [Related]
3. Cisplatin ototoxicity involves organ of Corti, stria vascularis and spiral ganglion: modulation by alphaMSH and ORG 2766.
Hamers FP; Wijbenga J; Wolters FL; Klis SF; Sluyter S; Smoorenburg GF
Audiol Neurootol; 2003; 8(6):305-15. PubMed ID: 14566101
[TBL] [Abstract][Full Text] [Related]
4. Cisplatin ototoxicity and the possibly protective effect of alpha-melanocyte stimulating hormone.
Heijmen PS; Klis SF; De Groot JC; Smoorenburg GF
Hear Res; 1999 Feb; 128(1-2):27-39. PubMed ID: 10082280
[TBL] [Abstract][Full Text] [Related]
5. Systemic co-treatment with alpha-melanocyte stimulating hormone delays hearing loss caused by local cisplatin administration in guinea pigs.
Wolters FL; Klis SF; de Groot JC; Hamers FP; Prieskorn DM; Miller JM; Smoorenburg GF
Hear Res; 2003 May; 179(1-2):53-61. PubMed ID: 12742238
[TBL] [Abstract][Full Text] [Related]
6. Application of a neuroprotective ACTH(4-9) analog to affect cisplatin ototoxicity: an electrocochleographic study in guinea pigs.
Hamers FP; Klis SF; Gispen WH; Smoorenburg GF
Eur Arch Otorhinolaryngol; 1994; 251(1):23-9. PubMed ID: 8179863
[TBL] [Abstract][Full Text] [Related]
7. Cisplatin ototoxicity in the guinea pig: vestibular and cochlear damage.
Sergi B; Ferraresi A; Troiani D; Paludetti G; Fetoni AR
Hear Res; 2003 Aug; 182(1-2):56-64. PubMed ID: 12948602
[TBL] [Abstract][Full Text] [Related]
8. Dose-dependent effect of 8-day cisplatin administration upon the morphology of the albino guinea pig cochlea.
Cardinaal RM; de Groot JC; Huizing EH; Veldman JE; Smoorenburg GF
Hear Res; 2000 Jun; 144(1-2):135-46. PubMed ID: 10831872
[TBL] [Abstract][Full Text] [Related]
9. Ultrastructural changes in the albino guinea pig cochlea at different survival times following cessation of 8-day cisplatin administration.
Cardinaal RM; De Groot JC; Huizing EH; Smoorenburg GF; Veldman JE
Acta Otolaryngol; 2004 Mar; 124(2):144-54. PubMed ID: 15072416
[TBL] [Abstract][Full Text] [Related]
10. Cisplatin-induced ototoxicity: morphological evidence of spontaneous outer hair cell recovery in albino guinea pigs?
Cardinaal RM; de Groot JC; Huizing EH; Veldman JE; Smoorenburg GF
Hear Res; 2000 Jun; 144(1-2):147-56. PubMed ID: 10831873
[TBL] [Abstract][Full Text] [Related]
11. Perilymphatic application of cisplatin over several days in albino guinea pigs: dose-dependency of electrophysiological and morphological effects.
O'Leary SJ; Klis SF; de Groot JC; Hamers FP; Smoorenburg GF
Hear Res; 2001 Apr; 154(1-2):135-45. PubMed ID: 11423224
[TBL] [Abstract][Full Text] [Related]
12. Ototoxicity of the new platinum anticancer agent TRK-710 in comparison with cisplatin.
Saito T; Manabe Y; Saito H
ORL J Otorhinolaryngol Relat Spec; 1995; 57(5):250-5. PubMed ID: 8587776
[TBL] [Abstract][Full Text] [Related]
13. Perilymphatic application of alpha-melanocyte stimulating hormone ameliorates hearing loss caused by systemic administration of cisplatin.
Wolters FL; Klis SF; Hamers FP; de Groot JC; Smoorenburg GF
Hear Res; 2004 Mar; 189(1-2):31-40. PubMed ID: 14987750
[TBL] [Abstract][Full Text] [Related]
14. Comparison of five agents in protecting the cochlea against the ototoxic effects of cisplatin in the hamster.
Kaltenbach JA; Church MW; Blakley BW; McCaslin DL; Burgio DL
Otolaryngol Head Neck Surg; 1997 Nov; 117(5):493-500. PubMed ID: 9374173
[TBL] [Abstract][Full Text] [Related]
15. Cisplatin-induced hyperactivity in the dorsal cochlear nucleus and its relation to outer hair cell loss: relevance to tinnitus.
Kaltenbach JA; Rachel JD; Mathog TA; Zhang J; Falzarano PR; Lewandowski M
J Neurophysiol; 2002 Aug; 88(2):699-714. PubMed ID: 12163523
[TBL] [Abstract][Full Text] [Related]
16. Protective effects of a neurotrophic ACTH(4-9) analog on cisplatin ototoxicity in relation to the cisplatin dose: an electrocochleographic study in albino guinea pigs.
Stengs CH; Klis SF; Huizing EH; Smoorenburg GF
Hear Res; 1998 Oct; 124(1-2):108-17. PubMed ID: 9822908
[TBL] [Abstract][Full Text] [Related]
17. Cisplatin-induced ototoxicity; electrophysiological evidence of spontaneous recovery in the albino guinea pig.
Stengs CH; Klis SF; Huizing EH; Smoorenburg GF
Hear Res; 1997 Sep; 111(1-2):103-13. PubMed ID: 9307316
[TBL] [Abstract][Full Text] [Related]
18. Semiquantitative analysis by scanning electron microscopy of cochlear hair cell damage by ototoxic drugs.
Saito T; Manabe Y; Honda N; Yamada T; Yamamoto T; Saito H
Scanning Microsc; 1995 Mar; 9(1):271-80; discussion 280-1. PubMed ID: 8553022
[TBL] [Abstract][Full Text] [Related]
19. Co-treatment with melanotan-II, a potent melanocortin, does not protect against cisplatin ototoxicity.
Wolters FL; de Vocht TF; Klis SF; Hamers FP; Smoorenburg GF
Hear Res; 2002 Oct; 172(1-2):110-7. PubMed ID: 12361873
[TBL] [Abstract][Full Text] [Related]
20. The ototoxicity of 3,3'-iminodipropionitrile: functional and morphological evidence of cochlear damage.
Crofton KM; Janssen R; Prazma J; Pulver S; Barone S
Hear Res; 1994 Nov; 80(2):129-40. PubMed ID: 7896571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
